Concepedia

G. Wiseman

GW

8

Publications

933

Citations

8

H-Index

2001

Active since

Affiliations

Mayo Clinic(Current)

Northwestern University

Townsville Hospital

James Cook University

University of California, Los Angeles

G. Wiseman is an author at Mayo Clinic specializing in medicine, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

2001–2018

8

Publications

8

A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.

Andrew M. Scott, G. Wiseman, Sydney Welt et al. · PubMed · 2003 · 441 citations

Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study

Leo I. Gordon, Arturo Molina, Thomas E. Witzig et al. · Blood · 2004 · 189 citations · Full text

Yttrium 90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Produces High Response Rates and Durable Remissions in Patients with Previously Treated B-Cell Lymphoma

Leo I. Gordon, Thomas E. Witzig, Arturo Molina et al. · Clinical Lymphoma · 2004 · 121 citations

, , +6

Radioembolisation for liver metastases: Results from a prospective 151 patient multi-institutional phase II study

Al B. Benson, Jean-François H. Geschwind, Mary F. Mulcahy et al. · European Journal of Cancer · 2013 · 86 citations

, , +10

Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse

Adam Robinson, Matthew Hankins, G. Wiseman et al. · Alimentary Pharmacology & Therapeutics · 2013 · 48 citations · Full text

Rows per page

1–5 of 8